Dublin, Jan. 20, 2026 (GLOBE NEWSWIRE) -- The "Yttrium Trichloride-90 Y (CAS 39271-65-3) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added ...

China has potentially revolutionized cancer therapy by producing Yttrium-90, a powerful beta-emitting isotope used to target liver tumors, using a commercial heavy-water reactor at the Qinshan Nuclear ...

Early Autologous Stem-Cell Transplantation Versus Conventional Chemotherapy as Front-Line Therapy in High-Risk, Aggressive Non-Hodgkin’s Lymphoma: An Italian Multicenter Randomized Trial Results: ...

Therapy-Related Myeloid Leukemias Are Observed in Patients With Chronic Lymphocytic Leukemia After Treatment With Fludarabine and Chlorambucil: Results of an Intergroup Study, Cancer and Leukemia ...

Singapore, 10 October 2024 – A study led by clinician-scientists and researchers from the National Cancer Centre Singapore (NCCS) and Singapore General Hospital (SGH) has determined the benefits of ...

Please provide your email address to receive an email when new articles are posted on . Y-90 resin microspheres are the only approved radioembolization therapy for hepatic cellular carcinoma and ...

Testing has been completed of a device for carrying out irradiation tests of various radioisotopes - such as yttrium-90 - at the two pressurised heavy water reactors that make up Phase III of the ...